What is he best known for?
The fields of study he is best known for:
Allan Balmain mainly focuses on Carcinogenesis, Cancer research, Immunology, Gene and Tumor suppressor gene.
Allan Balmain combines subjects such as Cell, Mutation, Tumor progression, Transforming growth factor beta and In vivo with his study of Carcinogenesis.
His Cancer research research integrates issues from Epithelium and Cancer.
His Immunology study combines topics in areas such as Malignant transformation, Malignancy, Skin cancer and Malignant Conversion.
His studies in Gene integrate themes in fields like Papilloma and DNA.
His research integrates issues of Transgene, TOR Serine-Threonine Kinases, Allele and Pathology in his study of Tumor suppressor gene.
His most cited work include:
- TGF-beta signaling in tumor suppression and cancer progression. (1950 citations)
- Guidelines for the welfare and use of animals in cancer research (937 citations)
- Carcinogen-specific mutation and amplification of Ha- ras during mouse skin carcinogenesis (754 citations)
What are the main themes of his work throughout his whole career to date?
Allan Balmain mostly deals with Cancer research, Carcinogenesis, Genetics, Gene and Molecular biology.
His research in Cancer research intersects with topics in Cancer, Mutation, Allele, Tumor suppressor gene and HRAS.
His studies deal with areas such as Computational biology, Bioinformatics and Carcinogen as well as Cancer.
Allan Balmain has researched Allele in several fields, including Wild type, Genotype and Locus.
Allan Balmain usually deals with Carcinogenesis and limits it to topics linked to Metastasis and Somatic evolution in cancer.
His work in Molecular biology tackles topics such as Cell culture which are related to areas like Mutant.
He most often published in these fields:
- Cancer research (41.13%)
- Carcinogenesis (39.52%)
- Genetics (25.00%)
What were the highlights of his more recent work (between 2010-2021)?
- Cancer research (41.13%)
- Carcinogenesis (39.52%)
- Genetics (25.00%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Cancer research, Carcinogenesis, Genetics, Cancer and Gene.
His biological study spans a wide range of topics, including Germline, KRAS, HRAS and Breast cancer, Estrogen receptor.
His study in HRAS is interdisciplinary in nature, drawing from both Squamous carcinoma and Metastasis.
Carcinogenesis is a subfield of Internal medicine that Allan Balmain studies.
The various areas that Allan Balmain examines in his Cancer study include Stem cell and Carcinogen.
His work carried out in the field of Allele brings together such families of science as Germline mutation, Genome-wide association study, Genome instability, Molecular biology and Locus.
Between 2010 and 2021, his most popular works were:
- The mutational landscapes of genetic and chemical models of Kras -driven lung cancer (206 citations)
- K-Ras Promotes Tumorigenicity through Suppression of Non-canonical Wnt Signaling. (114 citations)
- Keratin 16 regulates innate immunity in response to epidermal barrier breach (104 citations)
In his most recent research, the most cited papers focused on:
Cancer research, KRAS, HRAS, Carcinogenesis and Mutation are his primary areas of study.
His Cancer research research is multidisciplinary, incorporating elements of Epithelial–mesenchymal transition, Cancer, Wnt signaling pathway, Germline and Stem cell.
As a part of the same scientific family, Allan Balmain mostly works in the field of KRAS, focusing on Molecular biology and, on occasion, Proto-Oncogene Proteins p21, DNA, Cell aging, Chemical biology and Apoptosis.
Allan Balmain has included themes like Metastasis and Neuroblastoma RAS viral oncogene homolog in his HRAS study.
Carcinogenesis is frequently linked to Mutant in his study.
His Mutation research is classified as research in Gene.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
